Results 51 to 60 of about 258,658 (94)

Imaging of cerebrospinal fluid leakage from the cribriform plate. [PDF]

Radiol Case Rep
Sato T, Morishita Y, Suzuki J, Narita R, Uehara K, Kato E, Takase K.   +6 more
europepmc   +1 more source

Contemporary Management of Cerebrospinal Fluid Rhinorrhoea: A Review of the Literature. [PDF]

J Clin Med
Mughal Z, Martinez-Devesa P, Boukas A, Jeyaretna S, Qureishi A.   +4 more
europepmc   +1 more source

Associations of Cerebrospinal Fluid Orexin-A, Alzheimer Disease Biomarkers, and Cognitive Performance. [PDF]

Ann Clin Transl Neurol
Lu R, Shah K, Toedebusch CD, Hess A, Richardson R, Mignot E, Schindler SE, Benzinger TLS, Flores S, Hassenstab J, Xiong C, Morris JC, Holtzman DM, Lucey BP.   +13 more
europepmc   +1 more source

Distinct cerebrospinal fluid DNA methylation signatures linked to Alzheimer’s disease

Rados M, Klotz S, Regelsberger G, Stögmann E, Landegger LD, Fetahu IS.   +5 more
europepmc   +1 more source

Neurologic manifestations of COVID-19 and viral test in cerebrospinal fluid. [PDF]

PLoS One
Cardoso CO, Rodrigues Sandoval ES, de Oliveira Chagas LBM, Badra SJ, Covas DT, Haddad SK, Figueiredo LTM.   +6 more
europepmc   +1 more source

Serum and Cerebrospinal Fluid Malondialdehyde Levels in Patients with Mild Cognitive Impairment. [PDF]

J Xenobiot
Ioannidou S, Ginoudis A, Makedou K, Tsolaki M, Lymperaki E.   +4 more
europepmc   +1 more source

Mediation Effect of Relaxin in Cerebrospinal Fluid on the Association Between Smoking and Sleep. [PDF]

Nat Sci Sleep
Xu Z, Ma M, Liu Y, Tang J, Luo X, Chen YH, Wang K, Chen X, Kang Y, Zheng K, Hu W, Chen L, Wang F, Wu Y.   +13 more
europepmc   +1 more source

Aquaporin-4 as a cerebrospinal fluid biomarker of Alzheimer's disease. [PDF]

Transl Neurodegener
Gómez de San José N, Halbgebauer S, Steinacker P, Anderl-Straub S, Abu-Rumeileh S, Barba L, Oeckl P, Bellomo G, Gaetani L, Toja A, Mravinacová S, Bergström S, Månberg A, Grassini A, Rainero I, Nilsson P, Parnetti L, Otto M.   +17 more
europepmc   +1 more source

Comparison of cerebrospinal fluid biomarkers in patients with severe COVID-19 neurological outcomes and Alzheimer's disease. [PDF]

Brain Behav Immun Health
Barros-Aragão FGQ, Pinheiro TL, Pinto TP, Vanderborgh B, Rezende NBS, de Freitas GB, de Freitas GR, Bozza FA, Souza AS, Rodrigues EC, Brandão CO, Mattos P, Sudo FK, Tovar-Moll FF, De Felice FG.   +14 more
europepmc   +1 more source